Reproduction Products for the Animal Health Industry

Reproduction Products for the Animal Health Industry

Products

Animal Pharm Reports provides you with an essential overview of this small but important sector of the animal health market, analysing those factors driving it forward.

Reproduction Products for the Animal Health Industry looks at both commercial livestock and companion animals. The report enables you to understand the need for each product type and how it relates to changes in the management of each livestock and/or companion animal species. It allows you to evaluate the current trends in product usage and examine new developments. Current R&D areas are profiled and the likely direction of future research is evaluated, ensuring you can focus your product development programme accordingly.

Reproduction Products for the Animal Health Industry allows you to understand fully those factors driving the reproduction product sector in 18 geographical markets, ensuring that you can evaluate their possible impact on both your product portfolio and your national and global marketing plans. It also shows you how your competitors are performing, enabling you to assess and combat any future impact they may have on your market share.

PUBLISHED: OCTOBER 2000
REFERENCE: SR195E
PAGES: 132
PRICE: £395/$830/¥95,000

For further information about this report, please contact our Customer Helpdesk on:
Tel: +44 (0)20 8332 8965 / 66
Fax: +44 (0)20 8332 8992
E-mail: [email protected]

TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
EXECUTIVE SUMMARY
ABBREVIATIONS

CHAPTER 1 INTRODUCTION

CHAPTER 2 COMMERCIAL PRODUCTS
2.1 Background physiology
2.1.1 The oestrus cycle
2.1.2 External control of reproduction
2.1.2.1 Synchronisation
2.1.2.2 Superovulation
2.1.2.3 Other techniques
2.2 Products used in reproduction
2.2.1 Prostaglandins
2.2.1.1 Synthetic PGF_2alpha or analogues
2.2.2 Progesterone/progestogens
2.2.2.1 Products for cattle
2.2.2.2 Products for sheep
2.2.2.3 Products for horses and pigs
2.2.2.4 Products for dogs and cats
2.2.3 Anti-progesterone products
2.2.4 Gonadotrophins
2.2.5 Gonadotrophin-releasing hormones
2.2.6 Oestrogens
2.2.6.1 Oestradiol benzoate
2.2.6.2 Estriol
2.2.7 Oxytocin/pituitary extract
2.2.8 Androgens
2.2.9 Spasmolytics
2.2.9.1 Clenbuterol hydrochloride
2.2.9.2 Vetrabutine hydrochloride
2.2.9.3 Isoxsuprine hydrochloride
2.2.10 Melatonin
2.2.11 Prolactin antagonists
2.2.12 Lotrifen
2.2.13 Anti-oestrogens
2.2.14 Anti-androgens
2.2.15 Others
2.2.15.1 Homeopathic products
2.2.15.2 Corticosteroids
2.3 Diluents and media
2.3.1 Semen extender/diluent
2.3.2 Embryo transfer media
2.4 Detection of oestrus and pregnancy
2.4.1 Observation and examination of the animal
2.4.2 Use of heat detectors and paint markers
2.4.3 Use of hormone assays
2.5 Other test kits: semen analysis and embryo sexing

CHAPTER 3 TECHNIQUES IN CONTROLLED REPRODUCTION
3.1 Oestrus synchronisation
3.2 Artificial insemination
3.3 Embryo transfer
3.4 In vitro fertilisation
3.4.1 Bovine IVF
3.4.2 Equine IVF
3.5 Cloning
3.5.1 Overview
3.5.2 History
3.5.3 Concerns
3.5.4 Recent developments

CHAPTER 4 CURRENT RESEARCH AND NEW DEVELOPMENTS
4.1 Contraceptive vaccines
4.1.1 Wildlife population control
4.1.2 Control of ovulation
4.2 Equine breeding
4.2.1 Melatonin
4.2.2 Dopamine antagonists
4.2.3 Synthetic gonadotrophins
4.3 Carazolol
4.4 Sperm sexing
4.5 Embryo sexing
4.6 Pregnancy testing
4.7 Intelligent systems

CHAPTER 5 MARKET ANALYSIS BY COUNTRY
5.1 Overview
5.2 Australia and New Zealand
5.2.1 Australia
5.2.2 New Zealand
5.3 Western Europe
5.3.1 Denmark
5.3.2 France
5.3.3 Germany
5.3.4 Italy
5.3.5 Spain
5.3.6 UK
5.4 North America
5.4.1 Canada
5.4.2 US
5.5 Central and South America
5.5.1 Argentina
5.5.2 Brazil
5.5.3 Mexico
5.6 East Asia
5.6.1 China
5.6.2 Japan
5.6.3 Korea
5.7 India
5.8 South Africa

CHAPTER 6 COMPANY PROFILES
6.1 AB Technology Inc
6.2 BioResearch Ireland
6.3 Boehringer Ingelheim Vetmedica
6.4 Ceva Sant� Animale (formerly Sanofi)
6.5 Diagnostics Products Corporation
6.6 Drami�ski
6.7 Endocrine Technologies Inc
6.8 Fort Dodge Animal Health
6.9 Genetics Australia
6.10 Genus plc
6.11 Immucell Corporation
6.12 Immunodiagnostic Systems Ltd
6.13 InterAg
6.14 Intervet
6.15 Jurox
6.16 Merial Animal Health
6.17 Peptech Animal Health
6.18 Pfizer Animal Health
6.19 Pharmacia & Upjohn
6.20 Sankyo
6.21 Schering-Plough Animal Health
6.22 Sumitomo
6.23 Synbiotics Corporation US
6.24 Takeda Schering-Plough Animal Health
6.25 Thoroughbred Breeders Association Equine Fertility Unit
6.26 V�toquinol SA
6.27 Virbac

CHAPTER 7 CONTACT DETAILS FOR OTHER COMPANIES AND ASSOCIATIONS
7.1 Company contact details
7.2 Industry associations

REFERENCES AND FURTHER READING
APPENDIX 1 REGIONAL ANIMAL POPULATION STATISTICS BY COUNTRY, 1999

Executive Summary
The animal health market for reproduction products is a relatively small sector of the overall sales of veterinary products and is estimated to be worth around $168 million. Nonetheless, these products provide the necessary control over the reproductive process, which facilitate the more advanced techniques, and thus form the foundation of the latest technological achievements in controlled animal breeding.

This report, Reproduction Products for the Animal Health Industry, is both an update and a replacement of two previous Animal Pharm reports � Control of Reproduction (1987) and New Developments in Animal Reproduction and Breeding (1991). It provides information in an easy-to-read, concise style and is designed to offer the reader a valuable overview of this small, but important, sector of the animal health market. The content will be valuable for anyone with an interest in the current market situation, as well as for identifying future trends. The report is especially suited to product managers and marketing directors looking for an overview of the market and an evaluation of the future opportunities for the reproductive products sector of the animal health market.

The report includes a comprehensive review of products (including hormones and prostaglandins) used to control reproduction in animals, together with products and test kits used for oestrus detection and diagnosis of pregnancy. However, due to physiological differences, only domestic mammalian species are included. This report does not seek to include vaccines or antimicrobial products which may be used to control conditions of an infectious nature affecting the reproductive tract. Also excluded are ultrasound equipment and ancillary disposables, and other equipment such as catheters and artificial insemination collection apparatus.

The techniques used to control reproduction are briefly described and the associated use of any product is identified, so that the reader can appreciate the need for each product and how it relates to changes in the management of each livestock or companion animal species.

The text reviews how the products are used, highlights potential market opportunities, and seeks to identify trends, new developments and the likely direction of future research. The current market environment is reviewed by country and animal populations in each market are provided in Appendix 1 to allow regional comparisons by country. The key market players are profiled, and contact details for relevant companies, organisations and associations are provided.